About AmorChem
AmorChem is a Financial Services company based in Westmount (Canada) founded in 2011 by Elizabeth Douville and Ines Holzbaur, and was acquired by NuChem Therapeutics in February 2019. Biotech companies are funded by a venture capital firm. Its focus areas include Investment Industry, Venture Capital Funds, Independent Funds and Conventional VCs.
Company details
AmorChem was established in 2011 in Westmount, Canada, as a venture capital firm. Investments are directed toward early-stage biotechnology companies. Funding, strategic guidance, and operational support are provided to portfolio firms in the biotech sector. The firm operates primarily from Canada, with decisions guided by experienced partners. Focus is maintained on therapeutic innovations and life sciences advancements, supporting company growth through targeted capital deployment.
- Headquarters Westmount, Canada
- Founders Elizabeth Douville, Ines Holzbaur
- Stage Acquired
- SectorsFinancial Services
- Email••••••••
- Website amorchem.com
- Social LinkedIn X
- Acquired by NuChem Therapeutics (Feb 2019)
- Investors
- Acquired byNuChem Therapeutics
(Feb 2019)
Investors in AmorChem
AmorChem has secured backing from 1 investor. Prominent investors backing the company include NuChem Therapeutics.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
CRO offering preclinical small molecule drug discovery services | 2011 | nuchemtherapeutics.com | Montreal, Canada |
Investor details for AmorChem
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of AmorChem
3 people are tracked at AmorChem (3 in leadership).
| Name | Role | Group |
|---|---|---|
Elizabeth Douville | Co-Founder & Managing Partner | Leadership |
Ines Holzbaur | Co-Founder & Managing Partner | Leadership |
Kevin McBride | General Partner | Leadership |
Complete people profiles for AmorChem
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of AmorChem
2 dated milestones of AmorChem across 8 years, from founding to its latest funding, stage changes and deals.
- Founded AmorChem is founded.
- Exit Acquired by NuChem Therapeutics.
Web traffic of AmorChem
The website of AmorChem (amorchem.com) receives about 2K visits a month.
- Monthly visits2K
▲ 21.6% vs previous month
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about AmorChem
AmorChem was founded in 2011.
AmorChem is headquartered in Westmount, Canada. It is registered at Westmount, Quebec, Canada.
AmorChem was established in 2011 in Westmount, Canada, as a venture capital firm. Investments are directed toward early-stage biotechnology companies. Funding, strategic guidance, and operational support are provided to portfolio firms in the biotech sector. The firm operates primarily from Canada, with decisions guided by experienced partners. Focus is maintained on therapeutic innovations and life sciences advancements, supporting company growth through targeted capital deployment.
AmorChem has 1 investor. Key investors include NuChem Therapeutics.
Yes. AmorChem was acquired by NuChem Therapeutics in February 2019.